Today on Outsourcing-Pharma.com   Good news follows bad news for InVentiv Pharmaceutical outsourcing: people on the move CROs link arms to spread reach West unscathed by Exubera shot - for now 'World's first' NanoImaging service centre opens

Related Industry News   P&G in shock nasal spray exit Merck flexes muscle with GTx deal AstraZeneca CEO hacks at pipeline to up profits Why Pfizer's torcetrapib failure might not thwart other CETP inhibitors

Breaking News on Outsourcing Pharma
Daily  Thursday 08 November 2007		Forward to a colleague

	Company Profile DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here Access Full Stories Good news follows bad news for InVentiv After losing a key Novartis contract and getting caught up in the Inyx collapse, Inventiv Health had good news this week when it reported its third quarter results... Read Pharmaceutical outsourcing: people on the move INC Research, Quintiles, Bridge Pharmaceuticals, Charles River Laboratories and PharmaNet have all had people on the move in the world of pharmaceutical outsourcing... Read CROs link arms to spread reach This week two sets of contract research organisations (CROs) have announced plans to link arms in order to spread their reach further into this increasingly globalised marketplace... Read West unscathed by Exubera shot - for now West Pharmaceutical Services, one of the two firms responsible for manufacturing Pfizer's failed Exubera device, recently turned in its third quarter financials, so far avoiding any major dent from the company's... Read 'World's first' NanoImaging service centre opens NanoImaging Services has opened what it claims is a first of its kind first fee-for-service imaging business to enable structural characterisation and validation of biological drugs throughout the development... Read
	All News Headlines for: November | October | September
	Related Industry News P&G in shock nasal spray exit Procter & Gamble (P&G) has this week terminated an agreement with Nastech to develop a nasally delivered version of Eli Lilly's osteoporosis drug Forteo (teriparatide), leaving its partner with no explanation... Read Merck flexes muscle with GTx deal Merck & Co has inked a deal potentially worth over €507m (€346m) with GTx over a new class of drugs to treat muscle loss conditions, especially those caused by cancer... Read AstraZeneca CEO hacks at pipeline to up profits AstraZeneca's CEO has said the company will stop research in a number of diseases as it continues to cut costs and restructure in the face of falling sales... Read Why Pfizer's torcetrapib failure might not thwart other CETP inhibitors It was supposed to keep Pfizer at the top of the cardiovascular drug tree, but when torcetrapib failed, other pharma firms developing similar drugs looked on nervously to see if their drugs were also doomed. A... Read Weekly Comment Big pharma lends a helping hand Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis. Read Previous Headlines New counterfeit report highlights worrying trends A new report highlights a number of worrying trends emerging in regard to the increasing number of fake pharmaceuticals infiltrating supply chains around the globe... Read DSM third quarter results DSM's third quarter financial results are paving the way for the company's transition to a life sciences and material sciences company... Read New firm to tackle poor solubility head on A new Belgian company has joined the throng of pharmas tapping into the booming drug delivery business, but claims that its unique technologies will carve it a place as one of the industry's key players... Read PharmaNet makes a Q3 comeback PharmaNet has made a strong comeback during its third quarter after previously slipping into the red and recorded its highest revenue to date - $99.8m (€70.0m)... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, new deals have emerged involving MDS Pharma Services, Bruker Biospin and Expression Analysis... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com